Şunu aradınız:: if an alternate dose is required (İngilizce - Maltaca)

no dose adjustment is required
l-ebda aġġustament fid-doża

no dose adjustment is required,
l-ebda aġġustament fid-doża mhu meħtieġ.

no adjustment of methadone dose is required
ma huwa meħtieġ l-ebda tibdil

as an alternate member:
bħala membru supplenti:

if no further dose is required, remove the venipuncture set and syringe.
jekk ikun hemm bżonn li doża oħra tiġi mogħtija, uża siringa ġdida bil- prodott jiġi rikostitwit kif deskritt hawn fuq.

no change in dose is required for elderly patients.
m’hemmx bżonn ta’ bidla fid-doża għal pazjenti anzjani.

b) as an alternate member:
b) bħala membru supplenti:

no adjustment in starting dose is required for elderly patients.
mhux meħtieġ tibdil fid-doża tal-bidu għall-pazjenti anzjani.

elderly: no change in dose is required for elderly patients.
anzjani: m’hemmx għalfejn tibdil fid-doża fl-anzjani.

no adjustment of digoxin dose is required based on these results.
l-ebda aġġustament fid-doża ta’ digoxin mhu meħtieġ ibbażat fuq dawn ir-riżultati.

afterwards, your doctor may order blood tests to see if any adjustment in dose is required.
wara, t-tabib tiegħek jista’ jordna t- testijiet tad-demm biex jara jekk hemmx bżonn xi aġġustament fid-doża.

if a further dose is required, remove the empty syringe by turning it anti-clockwise.
jekk ikun hemm bżonn li doża oħra tiġi mogħtija, neħħi s- siringa l- vojta billi ddawarha kontra d- direzzjoni ta ’ l- arloġġ.

no adjustment of the initial dose is required in patients >65 years of age.
ma hemm l-ebda ħtieġa għal aġġustament tad-doża tal-bidu f’pazjenti > 65 sena.

patients with renal impairment: no change in dose is required for renal impairment.
pazjenti b’indeboliment renali: m’hemmx bżonn tibdil fid-doża meta jkun hemm indeboliment renali.

no adjustment of the fosamprenavir or ritonavir dose is required when co-administered with atovarstatin.
m’ hemmx bżonn ta ’ xi tibdil fid- doża ta ’ fosamprenavir jew ritonavir meta tingħata ma ’ atovarstatin.

since no increase to the dose is recommended, no change to the withdrawal period is required.
billi ma kienx hemm żieda fid- doża rrakkomandata, ma hemmx bżonn ta 'tibdil fil- perjodu ta' tneħħija.

clinical data suggest that no change in starting dose is required in patients with mild renal impairment.
dejta klinika ma tissuġġerixxi li l- ebda tibdil fid-doża tal-bidu ma hi meħtieġa f’pazjenti b’indeboliment tal-kliewi ħafif.

no adjustment of starting dose is required on the basis of race (see section 5.2).
l-ebda aġġustament fid-doża tal-bidu mhu meħtieġ ibbażat fuq ir-razza (ara sezzjoni 5.2).

no adjustment of the dose is required in patients ≥ 65 years old (see section 5.1).
mhux meħtieġ li jsir aġġustament fid-doża għal pazjenti ≥ 65 sena (ara sezzjoni 5.1).

in the absence of specific studies, no alternate dose recommendations for ellaone can be made.
fin-nuqqas ta’ studji speċifiċi, ma jistgħux isiru rakkomandazzjonijiet alternattivi dwar doża għal ellaone.